Apimeds PharmaceuticalsApimeds Pharmaceuticals
AP

Apimeds Pharmaceuticals

Pharmaceutical company focused on merger and financing activities.

Active

About

Apimeds Pharmaceuticals US, Inc. is a pharmaceutical company involved in merger and financing transactions. The company announced a settlement with Inscobee Inc. and Apimeds Inc. to resolve disputes arising from a merger with MindWave Innovations Inc. This settlement paves the way for the completion of the merger and a $100 million PIPE financing.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Apimeds Pharmaceuticals do?

Apimeds Pharmaceuticals US, Inc. is a pharmaceutical company involved in merger and financing transactions. The company announced a settlement with Inscobee Inc. and Apimeds Inc. to resolve disputes arising from a merger with MindWave Innovations Inc. This settlement paves the way for the completion of the merger and a $100 million PIPE financing.

How much funding has Apimeds Pharmaceuticals raised?

Apimeds Pharmaceuticals has raised a total of $100M in funding. The most recent round on record is PIPE.

Where is Apimeds Pharmaceuticals headquartered?

Apimeds Pharmaceuticals is headquartered in Matawan, New Jersey, US.

What industry does Apimeds Pharmaceuticals operate in?

Apimeds Pharmaceuticals operates in Pharmaceuticals, Biotechnology, Mergers & Acquisitions, Financing, Corporate Law.